Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk.

Neuro-degenerative diseases - 1 Jan 2014

Nordberg Agneta

Abstract excerpt

The time course and order of the pathological-physiological processes in Alzheimer's disease (AD) are still under investigation and it is expected that molecular imaging will provide important insight into early brain pathology. Multi-tracer positron emission tomography studies visualizing fibrillar amyloid, inflammatory changes including astrocytosis and activation of microglia as well as cerebral glucose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Imaging

Share to Positron-Emission Tomography

Share to Risk Factors

Source

Identifiers

PMID: 24434947
DOI: 10.1159/000356333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk.PMID 24434947Read ↗

Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.Semantic proximity Read ↗

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.Semantic proximity Read ↗

Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic InterventionSemantic proximity Read ↗

<i>APOE ε4</i> gene dose effect on imaging and blood biomarkers of glial reactivity and β-amyloid pathologySemantic proximity Read ↗

PET sheds light on Alzheimer's disease genetic risk.Semantic proximity Read ↗

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.Semantic proximity Read ↗

Beta-amyloid deposition and the aging brain.Semantic proximity Read ↗

Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.Semantic proximity Read ↗

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.Semantic proximity Read ↗

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.Semantic proximity Read ↗

Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.